drugset
drugset / Trial / NCT04519047

IA Injection of Rejoint Gel and PRP in Patients With Unilateral Knee OA

NCT04519047 ↗

Phase 1 Unknown 30 enrolled National Taiwan University Hospital The Industrial Technology Research Institute · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To assess the safety and tolerability of intra-articular Injection doses of Rejoint Gel after platelet-rich plasma administration in unilateral knee OA subjects.

Timeline

Start
2020-08-13
Primary completion
2020-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Platelet Rich Plasma Other / unclassified — Intravitreal

Indications

osteoarthritis, knee